The Medicines (Provision of False or Misleading Information and Miscellaneous Amendments) Regulations 2005

Made: 24th June 2005

Laid before Parliament: 1st July 2005

Coming into force-: 1st August 2005

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Citation and commencement

1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of the Medicines (Standard Provisions for Licences and Certificates) Regulations 1971

2

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994

3

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signed

Signed by authority of the Secretary of State for Health

Jane Kennedy — Minister of State, — Department of Health — 22 June 2005

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety

D G Gowdy — Permanent Secretary, — Department of Health, Social Services and Public Safety — 23 June 2005

Sealed with the Official Seal of the Department of Agriculture and Rural Development

Pat Toal — Permanent Secretary, — Department of Agriculture and Rural Development — 24 June 2005

Explanatory note

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Footnotes

[^f00001]: 1972 c. 68.

[^f00002]: S.I. 1972/1811.

[^f00003]: 1968 c. 67.

[^f00004]: In the case of the Secretary of State, by virtue of articles 2(1) and 5 of, and the Schedule to, S.I. 1999/3142, and articles 3(7) of and 5(2) of, and the Schedule to, S.I. 2002/794; and in the case of the Department of Health, Social Services and Public Safety and the Department of Agriculture and Rural Development, the powers vested in the Ministers in charge of those Departments by virtue of section 95(5) of, and paragraph 10 of Schedule 12 to, the Northern Ireland Act 1998 (c. 47) may now be exercised by the Departments by virtue of section 1(8) of, and paragraph 4(1)(b) of the Schedule to, the Northern Ireland Act 2000 (c. 1). The Departments were re-named by virtue of Article 3(4) and (6) of S.I. 1999/283 (N.I.1).

[^f00005]: S.I. 1971/972; relevant amendments were made by S.I. 1977/1053, 1983/1730, 1992/2846, 1993/833, 1994/103, 2002/236 and 2003/2321.

[^f00006]: The definition of “BCG vaccine” was inserted by regulation 2 of S.I. 1977/675.

[^f00007]: The definition of “imported proprietary product” was inserted by regulation 2 of S.I. 1977/1053.

[^f00008]: Inserted by S.I. 1993/2539 and amended by S.I. 2002/236 and 2003/2321.

[^f00009]: Inserted by S.I. 1992/2846.

[^f00010]: Inserted by S.I. 1992/2846.

[^f00011]: Inserted by S.I. 1983/1730.

[^f00012]: Paragraph 7A was inserted by S.I. 1993/833 and amended by S.I. 2002/236.

[^f00013]: OJ L311, 28.11.2001, p.67.

[^f00014]: Inserted by S.I. 1983/1730.

[^f00015]: S.I. 1994/3144; Schedule 3 has been amended by S.I. 1998/3105, 2000/292, 2002/236 and 2003/2321.

[^f00016]: See the definition of “the 2001 Directive” in regulation 1(2); Annex I was substituted by Commission Directive 2003/63/EC (OJ L159, 27.6.2003, p.46).

[^f00017]: OJ No. L214, 24.8.93, p.1.

[^f00018]: OJ No. L 311 28.11.2001, p.67.

Editorial notes

[^M_F_979f168a-2c09-49e4-be3e-98604e111e6c]: Regulations revoked (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 35 (with Sch. 32)